CH374645A - Process for the preparation of new thiocolchicine derivatives - Google Patents
Process for the preparation of new thiocolchicine derivativesInfo
- Publication number
- CH374645A CH374645A CH7650259A CH7650259A CH374645A CH 374645 A CH374645 A CH 374645A CH 7650259 A CH7650259 A CH 7650259A CH 7650259 A CH7650259 A CH 7650259A CH 374645 A CH374645 A CH 374645A
- Authority
- CH
- Switzerland
- Prior art keywords
- preparation
- general formula
- thiocolchicine
- new
- alkyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- CMEGANPVAXDBPL-INIZCTEOSA-N n-[(7s)-1,2,3-trimethoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5h-benzo[a]heptalen-7-yl]acetamide Chemical class C1([C@@H](NC(C)=O)CC2)=CC(=O)C(SC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC CMEGANPVAXDBPL-INIZCTEOSA-N 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- 150000002513 isocyanates Chemical class 0.000 claims description 3
- 150000002540 isothiocyanates Chemical class 0.000 claims description 3
- HFPMXDMZJUJZBX-AWEZNQCLSA-N Deacetylcolchicine Chemical class C1([C@@H](N)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC HFPMXDMZJUJZBX-AWEZNQCLSA-N 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000004414 alkyl thio group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical class C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- LGDSHSYDSCRFAB-UHFFFAOYSA-N Methyl isothiocyanate Chemical compound CN=C=S LGDSHSYDSCRFAB-UHFFFAOYSA-N 0.000 description 2
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- HBNYJWAFDZLWRS-UHFFFAOYSA-N ethyl isothiocyanate Chemical compound CCN=C=S HBNYJWAFDZLWRS-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000031864 metaphase Effects 0.000 description 2
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 2
- 238000001226 reprecipitation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NUNCOHUMTCDISK-AWEZNQCLSA-N (7s)-7-amino-1,2,3-trimethoxy-10-methylsulfanyl-6,7-dihydro-5h-benzo[a]heptalen-9-one Chemical compound C1([C@@H](N)CC2)=CC(=O)C(SC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC NUNCOHUMTCDISK-AWEZNQCLSA-N 0.000 description 1
- DLGUAUVHTOCKTB-UHFFFAOYSA-N 1-isocyanatononane Chemical compound CCCCCCCCCN=C=O DLGUAUVHTOCKTB-UHFFFAOYSA-N 0.000 description 1
- OMIHGPLIXGGMJB-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]hepta-1,3,5-triene Chemical compound C1=CC=C2OC2=C1 OMIHGPLIXGGMJB-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000003468 Ehrlich Tumor Carcinoma Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 235000016720 allyl isothiocyanate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940045695 antineooplastic colchicine derivative Drugs 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- -1 nausea Chemical compound 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- 229940117953 phenylisothiocyanate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
- C07C331/16—Isothiocyanates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Verfahren zur Herstellung von neuen Thiocolchicin-Derivaten
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von neuen Thiocolchicin-Derivaten der allgemeinen Formel I,
EMI1.1
in welcher Ri eine niedere Alkylmercaptogruppe und R2 eine Alkyl-, Alkenyl-, Alkinyl-oder Cycloalkylgruppe oder einen gegebenenfalls durch eine Hy- droxyl-, Alkoxyl-, Alkyl-, Nitro-oder Aminogruppe oder durch ein Halogenatom substituierten aromatischen oder heterocyclischen Rest bedeuten, und X für O oder S steht.
Gemäss dem Verfahren der vorliegenden Erfindung werden die neuen Derivate der Formel I hergestellt, indem man ein Desacetyl-colchicin-Derivat der allgemeinen Formel II,
EMI1.2
mit einem organischen Isocyanat bzw. Isothiocyanat der allgemeinen Formel III, R2-N=C=X III umsetzt und das Umsetzungsprodukt durch Kristallisation oder, falls es nicht kristallisiert, durch Ausfallen reinigt.
Das erfindungsgemässe Verfahren wird vorzugs- weise folgendermassen ausgeführt :
Ein Amin der Formel II wird in wenig abs.
Benzol gelöst und mit einer Lösung von 1. 1 Aquivalent Isocyanat bzw. Isothiocyanat in abs. Benzol versetzt. Nach 4-24 Stunden bei 20 erfolgt im allgemeinen Kristallisation, eventuell erst nach Ätherzugabe. Andernfalls werden die Produkte durch Ausfällen mit Petroläther gewonnen und durch Umfällen gereinigt. Man erhält so gelbe Kristalle bzw. amorphe Pulver, deren Schmelzpunkte nicht sehr charakteristisch sind, da sie meist von einer Zersetzung begleitet werden. Sie lösen sich in den meisten organischen Losungsmitteln leicht auf, so z. B. in Chloroform, Methylenchlorid und niederen Alkanoleny sind aber in Äther und Petroläther schwer löslich und unlöslich in Wasser.
Die Charakterisierung der Substanzen erfolgt durch Messung der molekularen Drehung und des Infrarot-Spektrums. Die Prüfung der Reinheit ist mittels der Papierchromatographie möglich.
Die neuen Thiocolchicin-Derivate zeichnen sich durch eine starke und selektive Hemmwirkung auf die Teilungsvorgänge im Zellkern bzw. durch spezifische mitosehemmende Eigenschaften aus. Bei der Prüfung in vitro an der Fibroblastenkultur hemmen sie die Zellteilung in der frühen Metaphase gleich stark, teilweise sogar stärker als bekannte Colchicinderivate. Die Prüfung in vivo erfolgte an dem experimentellen Ehrlichschen Ascitestumor der Maus : Bei intraperitonealer Verabreichung der Substanzen wird die Zellteilung in der frühen Metaphase wahrend. 10 bis 40 Stunden gänzlich gehemmt. Bei dieser langen Wirkungsdauer erweisen sich die neuen Verbindun- gen jedoch als nicht cytotoxisch und kaum allgemein toxisch.
Infolge dieser geringen Toxizität und des Fehlens der bekannten Nebenwirkungen des Colchi cins, wie Nausea, Erbrechen und Durchfall, sind sie in den verschiedenen klassischen Anwendungs- bereichen des Colchicins vorteilhaft verwendbar. Sie sollen in die Therapie eingeführt werden, stellen aber auch Zwischenprodukte zur Herstellung von Arznei- mitteln dar.
In den nachfolgenden Beispielen erfolgen alle Temperaturangaben in Celsiusgraden. Die Schmelz- punkte sind im evakuierten Röhrchen bestimmt und unkorrigiert.
Beispiel 1 N- (N'-Phenyl-thiocarbamido)-desacetyl- thiocolchicin
5 g kristallines Desacetyl-thiocolchicin werden in Chloroform gelöst und die Lösung im Vakuum zur Trockne gebracht. Der amorphe Rückstand wird in 50 cm3 abs. Benzol gelöst und mit 1,80 g Phenyl isothiocyanat in 5 cm3 Benzol versetzt. Nach 18 Stunden Stehen bei einer Temperatur von 200 wer- den die gelben Kristalle abgenutscht und mit Benzol Ather 1 : 1 gewaschen. Smp. 235-236 (Zers.), [al2t =-77 (c= 0, 935 in Chloroform).
Beispiel 2 N- (I'-Methyl-thiocarbamido)-desacetyl- thiocolchicin
Analog wie in Beispiel 1 wird mit Methyl-isothio- cyanat das im Titel genannte Derivat dargestellt.
Zers. P. 190-201 ; [C] 21 = Chloroform).
Beispiel 3 N- (N'-Athyl-thiocarbamido)-desacetyl- thiocolchicin
Analog wie in Beispiel 1 wird mit Athyl-isothiocyanat das im Titel genannte Derivat dargestellt.
Zers. P. 170-1870 ; ta] E) l =-109 (c = 0, 830 in Chloroform).
Beispiel 4 N- (N'-Allyl-thiocarbamido)-desacetyl- thiocolchicin
Analog wie in Beispiel 1 wird mit Allyl-isothiocyanat das im Titel genannte Derivat dargestellt.
Zers. P. 2392460. [a] 21 =-115 (c = 0,780 in Chloroform).
Beispiel S
N- (N'-a-Naphthyl-carbamido)-desacetyl- thiocolchicin
Analog wie in Beispiel 1 wird mit a-Naphthyl- isocyanat das im Titel genannte Derivat dargestellt.
Smp. 200-202 (Zers.) ; [a] 2D2= +200 (c = 0,935 in Chloroform).
Beispiel 6 N- (N'-Phenyl-carbamido)-desacetyl- thiocolchicin
Analog wie in Beispiel 1 wird mit Phenyl-iso- cyanat das im Titel genannte Derivat dargestellt.
Da das Produkt nicht zur Kristallisation gebracht werden kann, wird es durch Eintropfen der Benzollösung in Petroläther ausgefällt. Beim Umfällen aus Methylenchlorid-Petroläther erhält man ein reines Produkt vom Smp. 175-185 (Zers.) ; [iDt =-119 (c = 0,43 in Chloroform).
Beispiel 7 N-w-n-Nonyl-carbamido)-desacetyl- thiocolchicin
Analog wie in Beispiel 1 wird mit n-Nonyl-isocyanat das im Titel genannte Derivat dargestellt.
Die Reindarstellung erfolgt wiederum wie in Beispiel 6 durch Ausfällen mit Petroläther. Smp. 120-140 D-670 (c = 0,705 in Chloroform).
Process for the preparation of new thiocolchicine derivatives
The present invention relates to a process for the preparation of new thiocolchicine derivatives of the general formula I,
EMI1.1
in which Ri is a lower alkyl mercapto group and R2 is an alkyl, alkenyl, alkynyl or cycloalkyl group or an aromatic or heterocyclic radical which is optionally substituted by a hydroxyl, alkoxyl, alkyl, nitro or amino group or by a halogen atom, and X is O or S.
According to the process of the present invention, the new derivatives of the formula I are prepared by adding a deacetylcolchicine derivative of the general formula II,
EMI1.2
with an organic isocyanate or isothiocyanate of the general formula III, R2-N = C = X III and the reaction product is purified by crystallization or, if it does not crystallize, by precipitation.
The method according to the invention is preferably carried out as follows:
An amine of the formula II is in a little abs.
Dissolved benzene and with a solution of 1. 1 equivalent of isocyanate or isothiocyanate in abs. Benzene added. After 4-24 hours at 20, crystallization generally takes place, possibly only after the addition of ether. Otherwise the products are obtained by precipitation with petroleum ether and purified by reprecipitation. Yellow crystals or amorphous powders are obtained in this way, the melting points of which are not very characteristic, since they are usually accompanied by decomposition. They dissolve easily in most organic solvents, e.g. B. in chloroform, methylene chloride and lower Alkanoleny are sparingly soluble in ether and petroleum ether and insoluble in water.
The substances are characterized by measuring the molecular rotation and the infrared spectrum. The purity can be checked using paper chromatography.
The new thiocolchicine derivatives are characterized by a strong and selective inhibitory effect on the division processes in the cell nucleus or by specific mitosis-inhibiting properties. When tested in vitro on the fibroblast culture, they inhibit cell division in the early metaphase to the same extent, sometimes even more so than known colchicine derivatives. The in vivo test was carried out on the experimental Ehrlich ascites tumor of the mouse: When the substances are administered intraperitoneally, cell division is maintained in the early metaphase. Completely inhibited for 10 to 40 hours. With this long duration of action, however, the new compounds prove to be non-cytotoxic and hardly generally toxic.
As a result of this low toxicity and the lack of the known side effects of colchicine, such as nausea, vomiting and diarrhea, they can advantageously be used in the various classic areas of application of colchicine. They are to be introduced into therapy, but also represent intermediate products for the manufacture of drugs.
In the following examples, all temperatures are given in degrees Celsius. The melting points are determined and uncorrected in the evacuated tube.
Example 1 N- (N'-phenyl-thiocarbamido) -desacetyl-thiocolchicine
5 g of crystalline deacetyl-thiocolchicine are dissolved in chloroform and the solution is brought to dryness in vacuo. The amorphous residue is in 50 cm3 abs. Dissolved benzene and mixed with 1.80 g of phenyl isothiocyanate in 5 cm3 of benzene. After standing for 18 hours at a temperature of 200, the yellow crystals are suction filtered and washed with benzene ether 1: 1. M.p. 235-236 (dec.), [Al2t = -77 (c = 0.935 in chloroform).
Example 2 N- (I'-methyl-thiocarbamido) -desacetyl-thiocolchicine
As in Example 1, the derivative mentioned in the title is prepared using methyl isothiocyanate.
Decomp. P. 190-201; [C] 21 = chloroform).
Example 3 N- (N'-Ethyl-thiocarbamido) -desacetyl-thiocolchicine
As in Example 1, the derivative mentioned in the title is prepared using ethyl isothiocyanate.
Decomp. P. 170-1870; ta] E) l = -109 (c = 0.830 in chloroform).
Example 4 N- (N'-Allyl-thiocarbamido) -desacetyl-thiocolchicine
As in Example 1, the derivative mentioned in the title is prepared using allyl isothiocyanate.
Decomp. P. 2392460. [a] 21 = -115 (c = 0.780 in chloroform).
Example p
N- (N'-a-naphthyl-carbamido) -desacetyl-thiocolchicine
Analogously to Example 1, the derivative mentioned in the title is represented with a-naphthyl isocyanate.
M.p. 200-202 (dec.); [a] 2D2 = +200 (c = 0.935 in chloroform).
Example 6 N- (N'-phenyl-carbamido) -desacetyl-thiocolchicine
As in Example 1, the derivative mentioned in the title is prepared using phenyl isocyanate.
Since the product cannot be made to crystallize, it is precipitated by dripping the benzene solution into petroleum ether. Reprecipitation from methylene chloride petroleum ether gives a pure product with a melting point of 175-185 (decomp.); [iDt = -119 (c = 0.43 in chloroform).
Example 7 N-w-n-Nonyl-carbamido) -desacetyl-thiocolchicine
As in Example 1, the derivative mentioned in the title is prepared using n-nonyl isocyanate.
The pure preparation takes place again as in Example 6 by precipitation with petroleum ether. 120-140 D-670 (c = 0.705 in chloroform).
Claims (1)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH7650259A CH374645A (en) | 1959-08-03 | 1959-08-03 | Process for the preparation of new thiocolchicine derivatives |
| GB25799/60A GB935187A (en) | 1959-08-03 | 1960-07-25 | Improvements in or relating to thiocolchicine compounds |
| ES0260061A ES260061A1 (en) | 1959-08-03 | 1960-08-01 | Improvements in or relating to thiocolchicine compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH7650259A CH374645A (en) | 1959-08-03 | 1959-08-03 | Process for the preparation of new thiocolchicine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH374645A true CH374645A (en) | 1964-01-31 |
Family
ID=4534977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH7650259A CH374645A (en) | 1959-08-03 | 1959-08-03 | Process for the preparation of new thiocolchicine derivatives |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH374645A (en) |
-
1959
- 1959-08-03 CH CH7650259A patent/CH374645A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT343666B (en) | PROCESS FOR THE PRODUCTION OF NEW PIPERAZINE DERIVATIVES | |
| DE68917129T2 (en) | WATER-SOLUBLE ANTINEOPLASTIC TAXOL DERIVATIVES. | |
| DE68929275T2 (en) | CC-1065 analogs with two CPI subunits | |
| DE2530577C2 (en) | ||
| CH374645A (en) | Process for the preparation of new thiocolchicine derivatives | |
| DE3241764A1 (en) | NEW AZINO RIFAMYCINE | |
| CH622518A5 (en) | Process for the preparation of novel ergoline compounds | |
| DE2129637C2 (en) | 6-Phenylacetamido-6-methoxy (or ethoxy) penicillanic acid and salts and benzyl esters of these compounds, processes for their preparation and pharmaceuticals | |
| DE929609C (en) | Process for the production of piperazides of the lysergic acid series | |
| DE2557792A1 (en) | NEW HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USES | |
| CH376123A (en) | Process for the preparation of new thiocolchicine derivatives | |
| AT201245B (en) | Process for the production of new derivatives of the lysergic acid series substituted on the indole nitrogen | |
| DE1805280C3 (en) | Process for the preparation of cyclopeptides, certain cyclopeptides and pharmaceutical compositions containing them | |
| CH391694A (en) | Process for the preparation of new thiocolchicine derivatives | |
| DE1142613B (en) | Process for the preparation of deacetyl-thiocolchicine derivatives | |
| AT376221B (en) | METHOD FOR PRODUCING NEW ERGOL DERIVATIVES | |
| AT349484B (en) | PROCESS FOR PRODUCING NEW THIENOTHIAZINE DERIVATIVES | |
| DD146598A5 (en) | PROCESS FOR THE PREPARATION OF 4,5-DIPHENYL-OXAZOLE DERIVATIVES | |
| AT371470B (en) | METHOD FOR PRODUCING NEW ORGANIC COMPOUNDS | |
| AT214448B (en) | Process for the preparation of the new 10- (N-β-hydroxyethyl-piperazinyl-N'-propyl) -2-chloro-phenothiazine-5-oxide | |
| CH506505A (en) | Antitubercular thiourea derivs prepn | |
| AT370102B (en) | METHOD FOR PRODUCING NEW ERGOL DERIVATIVES | |
| AT206900B (en) | Process for the preparation of new 1-amino-2,4-dioxo-azetidine derivatives | |
| DE1150992B (en) | Process for the preparation of N- (3 ', 4', 5'-trimethoxybenzoyl) -desacetyl-thiocolchicine | |
| PL45616B1 (en) |